{"id":"https://openalex.org/W1987335802","doi":"https://doi.org/10.1016/j.bmcl.2006.11.025","title":"Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups\u2014new classes of PPAR \u03b3/\u03b4 and PPAR \u03b1/\u03b3/\u03b4 agonists","display_name":"Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups\u2014new classes of PPAR \u03b3/\u03b4 and PPAR \u03b1/\u03b3/\u03b4 agonists","publication_year":2006,"publication_date":"2006-11-16","ids":{"openalex":"https://openalex.org/W1987335802","doi":"https://doi.org/10.1016/j.bmcl.2006.11.025","mag":"1987335802","pmid":"https://pubmed.ncbi.nlm.nih.gov/17157013"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2006.11.025","doi":"https://doi.org/10.1016/j.bmcl.2006.11.025","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2006.11.025","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035462796","display_name":"Louis\u2010David Cantin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Louis-David Cantin","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA. david.cantin.b@bayer.com","Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA. david.cantin.b@bayer.com","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109427740","display_name":"Sidney X. Liang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sidney Liang","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067335133","display_name":"Herbert Ogutu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert Ogutu","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017480666","display_name":"Christiana I. Iwuagwu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christiana I. Iwuagwu","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000047038","display_name":"Ken Boakye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Boakye","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"William H. Bullock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William H. Bullock","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083142154","display_name":"Michael G. Burns","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Burns","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Roger Clark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roger Clark","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110358113","display_name":"Thomas H. Claus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Claus","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034099664","display_name":"Fernando E. delaCruz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fernando E. delaCruz","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michelle Daly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Daly","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065307122","display_name":"Frederick J. Ehrgott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick J. Ehrgott","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057695381","display_name":"Jeffrey S. Johnson","orcid":"https://orcid.org/0000-0001-8882-9881","observed_orcids":["https://orcid.org/0000-0001-8882-9881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey S. Johnson","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032497997","display_name":"Christine Keiper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine Keiper","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114009400","display_name":"James N. Livingston","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James N. Livingston","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055745677","display_name":"Robert W. Schoenleber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert W. Schoenleber","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052801374","display_name":"Jeffrey Shapiro","orcid":"https://orcid.org/0000-0002-7222-9213","observed_orcids":["https://orcid.org/0000-0002-7222-9213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Shapiro","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher Town","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Town","raw_affiliation_strings":["Department of Research Technologies, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research Technologies, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101560260","display_name":"Ling Yang","orcid":"https://orcid.org/0000-0002-5506-7021","observed_orcids":["https://orcid.org/0000-0002-5506-7021","https://orcid.org/0000-0003-1540-4385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ling Yang","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062858105","display_name":"Manami Tsutsumi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manami Tsutsumi","raw_affiliation_strings":["Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108239560","display_name":"Xin Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Ma","raw_affiliation_strings":["Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry Research, Bayer Pharmaceuticals Corporation, West Haven, CT 06516, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5035462796"],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.3368,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.49773022,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"17","issue":"4","first_page":"1056","last_page":"1061"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppar-agonists","display_name":"PPAR agonists","score":0.8629999756813049},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.7070000171661377},{"id":"https://openalex.org/keywords/ppardelta","display_name":"PPAR\u03b4","score":0.996999979019165},{"id":"https://openalex.org/keywords/pparalpha","display_name":"PPAR\u03b1","score":0.953000009059906},{"id":"https://openalex.org/keywords/receptor-subtype-selectivity","display_name":"receptor subtype selectivity","score":0.7860000133514404},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5960000157356262},{"id":"https://openalex.org/keywords/cardiovascular-complications","display_name":"cardiovascular complications","score":0.722000002861023},{"id":"https://openalex.org/keywords/blood-glucose-reduction","display_name":"blood glucose reduction","score":0.7490000128746033},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9100000262260437},{"id":"https://openalex.org/keywords/ppar-ligands","display_name":"PPAR ligands","score":0.7820000052452087}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9071732759475708},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.8216557502746582},{"id":"https://openalex.org/C2781076698","wikidata":"https://www.wikidata.org/wiki/Q718074","display_name":"Aryl","level":3,"score":0.6646534204483032},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.6002247333526611},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5419256687164307},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.5025291442871094},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4770071804523468},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4542085528373718},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4457198977470398},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.41924065351486206},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4070550799369812},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3670074939727783},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32421305775642395},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27490004897117615},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0854983925819397},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006868","descriptor_name":"Hydrolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007202","descriptor_name":"Indicators and Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008075","descriptor_name":"Lipoproteins, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D047494","descriptor_name":"PPAR delta","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2006.11.025","doi":"https://doi.org/10.1016/j.bmcl.2006.11.025","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2006.11.025","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:17157013","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17157013","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1523055845","https://openalex.org/W1977272810","https://openalex.org/W1978018331","https://openalex.org/W2004885518","https://openalex.org/W2028212562","https://openalex.org/W2038190722","https://openalex.org/W2114041992","https://openalex.org/W2144829836","https://openalex.org/W2146788074","https://openalex.org/W4211176707","https://openalex.org/W4240940664"],"related_works":["https://openalex.org/W2088660229","https://openalex.org/W2038190722","https://openalex.org/W1976520134","https://openalex.org/W2088972227","https://openalex.org/W2958620854","https://openalex.org/W2180128308","https://openalex.org/W2142769796","https://openalex.org/W2017961763","https://openalex.org/W2072037699","https://openalex.org/W2002851125"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}